ArticlePharmacogenomics and personalized medicine2019

Genetic polymorphisms of CYP3A5, CHRM2, and ZNF498 and their association with epilepsy susceptibility: a pharmacogenetic and case-control study.

Laith N Al-Eitan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.